Tamarack Advisers’s Amgen AMGN Stock Holding History

Tamarack Advisers’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-250	Closed	-$11K	–	32
2019 Q2	$11K	Buy	+250	New	+$44.8K	﹤0.01%	21
2018 Q4	–	Sell	-200	Closed	-$197K	–	23
2018 Q3	$197K	Buy	+200	New	+$39.4K	0.06%	29

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Tamarack Advisers's AMGN Position: Q2 2023 in Review

Tamarack Advisers sold out of Amgen (AMGN) in Q2 2023, closing a stake of 30,000 shares — an estimated $7.25M sold.

Tamarack Advisers first reported a position in AMGN in Q4 2016 and held it in 4 quarters. The position peaked at $7.25M in Q1 2023. 2,391 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

Tamarack Advisers reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
Tamarack Advisers sold 30,000 Amgen shares in Q2 2023, an estimated $7.25M.
Tamarack Advisers first reported a position in Amgen in Q4 2016 and held it in 4 quarters.
Tamarack Advisers's Amgen position peaked at $7.25M in Q1 2023.
2,391 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on Tamarack Advisers's 13F filing for Q2 2023, filed 10 Aug 2023.